Head of market access, North Africa (Egypt, Libya, Sudan and Jordan), Janssen Pharmaceuticals.
July 2015- Nov 2017
HEMAR (Health Economics, Market Access and Reimbursement) Manager North Africa (Egypt, Libya, Sudan and Jordan), Janssen Pharmaceuticals.
Oct 2014-July 2015:
Senior Regional HEMAR (Health Economics, Market Access and Reimbursement) and Regulatory Associate, North Africa (Egypt, Libya, Sudan and Jordan), Janssen Pharmaceuticals.
September 2012-Oct 2014:
Technical office Manager CAPA (Central Administration of Pharmaceutical Affairs).
December 2012- Oct 2014:
Member of the pharmaco-economics steering committee, CAPA.
October 2012-Oct 2014:
Supply chain Reform program management team member, MOH.
October 2012- Oct 2014:
Executive manager for the e-CTD (electronic common technical document) implementation project
January 2014- Oct 2014:
The Egyptian regulatory counterpart, AFRA (African Regional Cooperative Agreement For Research, Development And Training Related To Nuclear Science And Technology), (IAEA) International Atomic Energy Agency
August 2009-August 2010
Head of Biocides Registration Department, Ministry of Health, Egypt
Labeling and naming committee Member for human drugs, food supplements and biological products
Registration Specialist, human Pharmaceutical product.
Pharmacology Instructor, Faculty of Pharmacy October 6th University, Cairo.
Elsisi GH, Ragab S, Ashraf R, Elmahdawy M. Cost-Effectiveness of Drug-Eluting Stents versus Bare Metal Stents in Egyptian Diabetic Patients. Poster Presentation PCV108 at ISPOR 16th Annual European Congress 2-6 November 2013; Dublin, Ireland.